OVERVIEW

• Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK1.
• India accounts for 20 per cent of global exports in generics. India’s pharmaceutical exports stood at US$ 8.02 billion in FY20 (up to September 2019). The exports are expected to reach US$ 20 billion by 2020.
• Indian pharmaceutical sector is expected to grow at a CAGR of 22.4 per cent in the near future and medical device market expected to grow US$ 55 billion by 2020. India is the second largest contributor of global biotech and pharmaceutical workforce. The pharmaceutical sector was valued at US$ 33 billion in 2017.
• Indian healthcare sector, one of the fastest growing sectors, is expected to cross US$ 372 billion by 2022.
• By 2024-25, India’s biotech industry is estimated to increase to US$ 100 billion